Marjolein de Bruin-Weller

Marjolein de Bruin-Weller is full Professor and head of the National Expertise Center of Atopic Dermatitis, situated in the dpt. of Dermatology and Allergology of the University Medical Center Utrecht, The Netherlands.

Her major interest is clinical and translational research in atopic dermatitis. She is the principal investigator in several clinical trials and investigator-initiated studies focused on difficult to treat atopic dermatitis and systemic immunosuppressive and immuno-modulating treatment. 

In 2018 she initiated the BioDay Registry in the Netherlands together with dr. Marie-Louise Schuttelaar from the department of Dermatology of the University Medical Center of Groningen. This registry is focused on the new advanced systemic treatments in atopic dermatitis and includes a lot of data regarding  atopic dermatitis (signs, symptoms, quality of life, work impairment) as well as data on atopic co-morbidities. Currently  > 2000 patients from 20 sites in the Netherlands are included in the BioDay registry.

Together with Femke van Wijk, professor of tissue immunology at the Center of Translational Immunology (CTI) of the University Medical Center Utrecht, she leads the translational Atopic Dermatitis research group.

Marjolein de Bruin-Weller is chair of the Expertise group Allergy and Eczema of the Dutch Society of Dermatology and Venereology and member of the European Task Force of Atopic Dermatitis (ETFAD) , the International Eczema Council (IEC) and the GA²LEN ADCARE Task Force. She is chair of the advisory board of the Dutch Patient Society for Atopic Dermatitis (VMCE) and member/chair of several Dutch committees regarding advanced systemic treatments in inflammatory diseases.